These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15883175)

  • 1. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
    Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE
    J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD; Laine L; Hughes S; Nicholson A; Galloway A; Gould FK
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.
    Mereghetti L; Marquet-van der Mee N; Loulergue J; Rolland JC; Audurier A
    Pathol Biol (Paris); 1998 May; 46(5):319-24. PubMed ID: 9769892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis.
    Zebouh M; Thomas C; Honderlick P; Lemee L; Segonds C; Wallet F; Husson MO
    J Cyst Fibros; 2008 May; 7(3):238-43. PubMed ID: 18498727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA; Mauldin PD; Steed LL
    Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed morphotype testing of Pseudomonas aeruginosa cultures from cystic fibrosis patients.
    Wolter JM; Kotsiou G; McCormack JG
    J Med Microbiol; 1995 Mar; 42(3):220-4. PubMed ID: 7884805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India.
    Agarwal G; Kapil A; Kabra SK; Chandra R; Das B; Diwedi SN
    Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Dunne WM; Chusid MJ
    Diagn Microbiol Infect Dis; 1987 Feb; 6(2):165-70. PubMed ID: 3102157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.
    Fothergill JL; Panagea S; Hart CA; Walshaw MJ; Pitt TL; Winstanley C
    BMC Microbiol; 2007 May; 7():45. PubMed ID: 17521417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis.
    Serisier DJ; Jones G; Tuck A; Connett G; Carroll MP
    Pediatr Pulmonol; 2003 Jun; 35(6):463-6. PubMed ID: 12746944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4809-15. PubMed ID: 19704123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and cost of antibiotic susceptibility testing of mixed morphotypes of Pseudomonas aeruginosa.
    Morlin GL; Hedges DL; Smith AL; Burns JL
    J Clin Microbiol; 1994 Apr; 32(4):1027-30. PubMed ID: 8027305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative effect of roxithromycin and rifampicin on mucoid cultures from directly plated sputum of cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa.
    Dupont MJ; Lapointe JR
    Drugs Exp Clin Res; 1990; 16(12):597-605. PubMed ID: 2130001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of a new E-test method for antimicrobial sensitivity testing of Pseudomonas aeruginosa isolates from cystic fibrosis].
    Zebouh M; Thomas C; Honderlick P; Lemee L; Segonds C; Wallet F; Husson MO
    Pathol Biol (Paris); 2005; 53(8-9):490-4. PubMed ID: 16087300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.